Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLH-2109 in uterine fibroids with menorrhagia and pain
NCT05445167Phase 3Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Oct 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linzagolix in Uterine Fibroids (UF), sponsored by Kissei Pharmaceutical Co., Ltd.. Started Oct 2022; status: completed.
02
Drugs
linzagolix
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT05445167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05445167.